Knight Initiative News

The shingles vaccine not only offers protection against the painful viral infection, a new study suggests that the two-dose shot also may slow the progression of dementia

Getting vaccinated against shingles could protect you from getting dementia, or slow the progression of the disease, says a new study

Knight Initiative scientists report that biology, behavior, and circumstance all intertwine over a lifetime to influence how organs grow old

Everything we know now, and what we hope and pray is coming

Amyotrophic lateral sclerosis and frontotemporal dementia are devastating neurodegenerative diseases. Knight Initiative postdoc Yi Zeng is working to understand the role a central protein plays in both diseases—and whether it might point toward new diagnostics and treatments

Neuroradiologist Raag Airan and his lab have found a non-invasive, drug-free method to help clean the brain, reduce inflammation, and treat disease—and with Knight Initiative for Brain Resilience support, they plan to test it in people soon.

The Knight Initiative’s Fall Symposium featured researchers building new molecular atlases of the brain alongside new updates on neurodegenerative disease and what might be done about it.

Research from Knight Initiative Director Tony Wyss-Coray's lab show that an Alzheimer's hallmark—myriad oily droplets in brain cells called microglia—may help connect several of the disorder’s better known but not well understood features.

Neurons are built to last, but with age, bad things can happen to them. Wu Tsai Neuro affiliate Katrin Andreasson's work shows a lot of it is triggered by what’s happening to immune cells outside of the brain.

Amyloid plaques have long been the focus of Alzheimer’s therapies. But Wu Tsai Neuro's Emmanuel Mignot and others are focusing on the stringy tangles of a protein called tau, the unsung second hallmark of Alzheimer’s.

Anne Brunet will receive a Director's Pioneer Award, and Bianxiao Cui will receive a Director's Transformative Research Award.

Studying mice of different ages, Stanford scientists and colleagues found that neurons involved in spatial memory become less reliable later in life.

The genetic variant APOE4, carried by one-fifth of the world’s people, substantially boosts Alzheimer’s risk. But scientists have been puzzled about how to reverse that risk: punch up the gene variant’s potency, or smack it down? Now we know, thanks to research funded by the Knight Initiative for Brain Resilience.

Researchers from around the university will collaborate to deepen our understanding of the brain.

Stanford's Office of Postdoctoral Affairs has named Hulya Torun one of this year's Postdoc Champions

A new study finds links between two popular models of the disease—and the results could change how researchers think about treatment.

Knight Initiative researchers are uncovering the fine points of how our brains learn to move. In the long run, their findings could help devise better treatments for Parkinson's disease.

Stanford undergrads and local community college students paired with Wu Tsai Neurosciences Institute researchers to find new ways to head off strokes, predict Alzheimer's disease, and more.

A study of killifish reveals how protein dysfunction develops in vertebrate brain cells, a key driver of aging – shedding light on cognitive decline and diseases like Alzheimer’s, Parkinson’s, and ALS.

Stanford researchers reviewed over 400 therapy evaluations and discovered a crucial mismatch: Mouse studies test disease prevention, while human trials test treatment of existing disease.